Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption

NCT03710889 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis, Postmenopausal
Osteoporosis
Osteoporosis Vertebral
Osteoporosis Risk
Osteoporosis Fracture
Osteoporosis Localized to Spine
Osteoporosis, Age-Related
Osteoporosis Senile
Osteoporosis of Vertebrae

Interventions

DRUG: Abaloparatide

Sponsor

Radius Health, Inc.